Eledon Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -11.61%
- Market cap
- $199.32M
- 84.46M shares
- Filings
- 617
Q1 2017
Q3 2026N/M FY25 yoy
Q3 2026N/M FY23 yoy
FY 2016derivedN/M FY16 yoy
Q3 2026N/M FY25 yoy
Q3 2026+11.0% FY25 yoy
- $199.32M
- —
- —
- 6.5×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2016 | 2016-12-31 | $0 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $0 | reported | |
| FY 2013 | 2013-12-31 | $0 | reported | |
| FY 2012 | 2012-12-31 | $0 | reported |
Pharmaceutical preparations
Eledon Pharmaceuticals, Inc. is the 249th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SIGASiga Technologies Inc$94.6M31.8%24.6%$209.1MTRDAEntrada Therapeutics, Inc.$25.4M87.9%565.5%$203.2M
ELDNEledon Pharmaceuticals, Inc. (this company)———$199.3M
KROSKeros Therapeutics, Inc.$244.1M6,775.0%35.7%$197.2MKRROKorro Bio, Inc.$6.4M181.5%1,834.5%$196.1MRNACCartesian Therapeutics, Inc.$2.8M92.8%4,658.6%$194.3MBBOTBridgeBio Oncology Therapeutics, Inc.———$191.4MPYXSPyxis Oncology, Inc.$13.9M14.2%574.5%$189.0MRNAAtrium Therapeutics, Inc.———$184.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR